BUY Le Travenues Technology Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)19 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Ixigo shares rally 13% after travel platform reports all-time high profit
NewsEt-Markets·19 Oct · 2d ago
Ixigo shares jump 13% on Q2 profit turnaround, but why does Motilal Oswal retain its Neutral rating?
NewsLivemint·19 Oct · 2d ago
Ixigo Q2 profit jumps to 63 cr; revenue up 13%
NewsEt-Markets·18 Oct · 3d ago
ixigo Q2 profit at Rs 63 cr on robust show in hotel booking biz
NewsEt-Markets·17 Oct · 4d ago
Ixigo Q2 Results: Net Profit Swings To Rs 61 Crore On One-Time Gain, Margin Expands
NewsNdtv-Profit·17 Oct · 4d ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·21 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Le Travenues Technology
- BUY — Kunal Hasmukhlal Shah22 Sept 2026 · ~3 months · target ₹180 · SL hit
- BUY — Motilal Oswal6 Aug 2026 · ~1 year · target ₹215 · Active
- BUY — Aditya Agarwal, Coheron Brokers1 Jul 2026 · ~2 weeks · target ₹215 · Expired
More from ICICI Securities
- BUY Just Dial21 Oct 2026 · ~1 year · target ₹850 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹230 · Active
- BUY Rossari Biotech20 Oct 2026 · ~1 year · target ₹520 · Active
- BUY Tatva Chintan Pharma Chem20 Oct 2026 · ~1 year · target ₹2,385 · Active
- BUY Crompton Greaves Consumer Electricals19 Oct 2026 · ~1 year · target ₹275 · Active

